Premium
Management of patients with ovarian cancer in the COVID‐19 era
Author(s) -
Bogani Giorgio,
Casarin Jvan,
Pinelli Ciro,
Donato Violante,
Bosio Sara,
Ruisi Simona,
Brusadelli Claudia,
Guerrisi Rocco,
Sarpietro Giuseppe,
Ditto Antonino,
Ghezzi Fabio,
Raspagliesi Francesco
Publication year - 2020
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.26057
Subject(s) - medicine , covid-19 , ovarian cancer , outbreak , disease , cancer , intensive care medicine , oncology , infectious disease (medical specialty) , pathology
Abstract At the beginning of 2020, coronavirus disease 2019 (COVID‐19) spreads worldwide. Patients with ovarian cancer should be considered at high‐risk of developing severe morbidity related to COVID‐19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID‐19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.